EFFECT OF ONO-5334, A NOVEL CATHEPSIN K INHIBITOR, ON BONE TURNOVER MARKERS IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Mori, H. [1 ]
Yamada, H. [1 ]
Kunishige, A. [1 ]
Nishikawa, S. [1 ]
Hashimoto, Y. [1 ]
Tanaka, M. [1 ]
Shiroya, T. [1 ]
机构：
[1] Ono Pharmaceut Co Ltd, Dev Res Labs, Osaka, Japan
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [21] Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
    Makoto Tanaka
    Yoshitaka Hashimoto
    Chihiro Hasegawa
    Steve Deacon
    Richard Eastell
    BMC Musculoskeletal Disorders, 18
  • [22] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    Eastell, R.
    Dijk, D. -J.
    Small, M.
    Greenwood, A.
    Sharpe, J.
    Yamada, H.
    Yuba, M.
    Tanimoto, M.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (01) : 309 - 318
  • [23] Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis
    Tanaka, Makoto
    Hashimoto, Yoshitaka
    Hasegawa, Chihiro
    Deacon, Steve
    Eastell, Richard
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [24] Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
    R. Eastell
    D.-J. Dijk
    M. Small
    A. Greenwood
    J. Sharpe
    H. Yamada
    M. Yuba
    M. Tanimoto
    S. Deacon
    Osteoporosis International, 2016, 27 : 309 - 318
  • [25] Population Pharmacokinetic and Pharmacodynamic Modeling of Different Formulations of ONO-5334, Cathepsin K Inhibitor, in Caucasian and Japanese Postmenopausal Females
    Hasegawa, Chihiro
    Ohno, Tomoya
    Umemura, Takeo
    Honda, Naoki
    Ohyama, Michiyo
    Nagase, Shinichi
    Small, Maria
    Deacon, Steve
    Ogawa, Mikio
    Ieiri, Ichiro
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (01): : 23 - 34
  • [26] SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL CATHEPSIN K INHIBITOR, ONO-5334, IN POSTMENOPAUSAL WOMEN: AN ASCENDING SINGLE AND MULTIPLE DOSE PHASE I STUDY
    Nagase, S.
    Hashimoto, Y.
    Ohyama, M.
    Kuwayama, T.
    Deacon, S.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 339 - 339
  • [27] Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
    Eastell, Richard
    Nagase, Shinichi
    Small, Maria
    Boonen, Steven
    Spector, Tim
    Ohyama, Michiyo
    Kuwayama, Tomohiro
    Deacon, Steve
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (02) : 458 - 466
  • [28] Modeling and Simulation of Bone Mineral Density Response From a Phase 2 Study of ONO-5334, a New Cathepsin K Inhibitor, to Support Dose Selection in Osteoporosis
    Hasegawa, Chihiro
    Kastrissios, Helen
    Monteleone, Jonathan
    Ohno, Tomoya
    Umemura, Takeo
    Ohyama, Michiyo
    Nagase, Shinichi
    Small, Maria
    Deacon, Steve
    Ogawa, Mikio
    Ieiri, Ichiro
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (08): : 937 - 948
  • [29] Antiresorptive activity of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis.
    Tanaka, Makoto
    Hashimoto, Yoshitaka
    Hasegawa, Chihiro
    Deacon, Steve
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S382 - S382
  • [30] EFFECTS OF THE CATHEPSIN K INHIBITOR, ONO-5334, ON BMD AS MEASURED BY 3D QCT IN THE HIP AND THE SPINE AFTER 12 MONTHS TREATMENT
    Engelke, Klaus
    Nagase, Shinichi
    Fuerst, Thomas
    Eastell, Richard
    Genant, Harry
    Small, Maria
    Kuwayama, Tomohiro
    Deacon, Steve
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 100 - 101
12345